Working… Menu

Phase I Intratumoral Pbi-shRNA STMN1 LP in Advanced and/or Metastatic Cancer (STMN1-LP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01505153
Recruitment Status : Completed
First Posted : January 6, 2012
Last Update Posted : February 22, 2018
Information provided by (Responsible Party):
Gradalis, Inc.